Huntingdon, UK 4/23/08—NextGen Sciences has announced that it plans to divest or dissolve its software and instrumentation business and its protein production business within the next six months. The company intends to focus on its life science–research service business, particularly biomarker services. The company also plans to move its headquarters to the US.
In the first of IBO’s twice yearly look at new labs, IBO covers new laboratory construction in China and Singapore, along with new laboratories in the nanotechnology sector, particularly on US college campuses. IBO’s report ends with a look at oil money’s advancement of new laboratory construction in the Middle East. Foreign multinational investment in […]
Agriculture: Across the globe, governments and biotech companies are attempting to reconcile food shortages and increasing food prices with strict regulations on genetically modified (GM) crops. In a recent move, food manufacturers in Japan and Korea have abandoned their adherence to unmodified corn, which has increased three times in price from 2006, for its GM […]
Government: The US government’s expansion of DNA collection to include everyone arrested for violation of a federal law is expected to further burden federal labs. One million additional profiles are expected to be added as a result. In response, the FBI has allocated an extra $2 million to its budget. State labs have also been […]
Company Announcements In 2007, ThalesNano opened a UK subsidiary and signed distribution agreement for Scandinavia, Italy and India. ThalesNano announced a collaboration for flow/microwave chemistry research with the Christian Doppler Laboratory for Microwave Chemistry at Karl Franzens University in Austria and with the Swiss Federal Institute of Technology Zurich. PolyGen named Blue Lion Biotech its […]
Company Announcements Invitrogen and PamGene will co-market Invitrogen’s Nuclear Hormone Receptor proteins and Lanthascreen assay technology with PamGene’s PamChip and PamStation Nuclear Hormone Receptor screening tools. Clinical Data and Affymetrix entered into a marketing agreement for a new drug metabolism service. Source BioScience will exclusively distribute Empire Genomics’ ACCUarray CGH genotyping technology in the UK. […]
Before the digital and automation age, cell counting was performed by using a microscope paired with a hemocytometer. While this decades-old manual method is still being utilized by labs, the primary advantage of this technique is its low cost. Its many drawbacks include a lack of precision, low accuracy, lot-to-lot variability and labor intensiveness. In […]
Ludwigshafen and Heidelberg, Germany 4/3/08—Chemical firm BASF SE has acquired a 75% stake plus one share in hte AG, a provider of high-throughput experimentation products and services for catalysis, material science and formulations. Hte’s owners included private equity firms 3i Group. Financial details were not disclosed. BASF previously owned 12.7% of the company, in which […]
As the largest market for particle size and distribution analysis, the pharmaceutical industry accounted for approximately 15% of the sales of instruments and aftermarket products last year. Particle size is a crucial metric for the design, quality control and manufacturing of pharmaceuticals. In developing new drugs, researchers are increasingly exploring the use of nano-sized particles […]
Japan: Japan’s recent experience, in which Chinese-manufactured, pesticide-laden gyoza poisoned 10 citizens, has prompted the government to restructure the inspection and labeling of imported and processed foods. Food inspection will now include tests for agricultural chemical residues, specifically organophosphorous pesticides. Such testing may prove difficult as Japan currently does not specify maximum residue limits for […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
